Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis

Robert F. Kushner*, Anders Fink-Jensen, Ofir Frenkel, Barbara McGowan, Bryan Goldman, Maria Overvad, Thomas Wadden

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Psychology